Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial

Yu L-M. et al, (2021)

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.

Ramakrishnan S. et al, (2021), Lancet Respir Med

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.

Ogbe A. et al, (2021), Nature communications, 12

Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice

Wang L. et al, (2021), Nature Genetics, 53, 500 - 510

Niche and local geography shape the pangenome of wastewater- and livestock-associated Enterobacteriaceae.

Shaw LP. et al, (2021), Sci Adv, 7

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2.

Townsend A. et al, (2021), Nat Commun, 12

Diagnosis of SARS-CoV-2 infection with LamPORE, a high-throughput platform combining loop-mediated isothermal amplification and nanopore sequencing.

Peto L. et al, (2021), J Clin Microbiol

Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following Tocilizumab therapy: A systematic review to inform risk assessment in the COVID era

Campbell C. et al, (2021)

Providing an Evidence Base for Tissue Sampling and Culture Interpretation in Suspected Fracture-Related Infection.

Dudareva M. et al, (2021), J Bone Joint Surg Am

Hospital at home: home-based end-of-life care.

Shepperd S. et al, (2021), Cochrane Database Syst Rev, 3

Trematode Proteomics: Recent Advances and Future Directions

Bennett APS. and Robinson MW., (2021), Pathogens, 10, 348 - 348

COVID-19 and liver disease: mechanistic and clinical perspectives.

Marjot T. et al, (2021), Nat Rev Gastroenterol Hepatol

SARS-CoV-2 within-host diversity and transmission

Lythgoe KA. et al, (2021), Science, eabg0821 - eabg0821

Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom

Buchanan J. et al, (2021), Applied Health Economics and Health Policy

Virological and serological characterization of critically ill patients with COVID-19 in the UK: a special focus on variant detection

Ratcliff J. et al, (2021)

‘These discussions aren’t happening’. Experiences of people living with inflammatory bowel disease talking about sexual well-being with healthcare professionals

Fourie S. et al, (2021), Journal of Crohn's and Colitis

In vivo negative regulation of SARS-CoV-2 receptor, ACE2, by interferons and its genetic control

Ansari MA. et al, (2021), Wellcome Open Research, 6, 47 - 47

‘Attorneys of the poor’: Training physicians to tackle health inequalities

FitzPatrick MEB. et al, (2021), Future Healthcare Journal, 8, 12 - 18

Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD

Bourbeau J. et al, (2021), International Journal of Chronic Obstructive Pulmonary Disease, Volume 16, 499 - 517

Deciphering the Transcriptomic Heterogeneity of Duodenal Coeliac Disease Biopsies

Wolf J. et al, (2021), INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?